论文部分内容阅读
对很多肿瘤晚期患者的现今治疗手段更多的有赖于放化疗,尤其是化学药物治疗。阻碍化疗成功的最大障碍是治疗的针对性差。其根本原因主要有两点:临床上未能使用最佳的药物和现今多数药物选择性差,导致对正常组织和功能的破坏。包括新生血管生成抑制剂(angiogenesis in-hibitor)[
Today’s treatments for many advanced cancer patients rely more on chemoradiation, especially chemotherapeutics. The biggest obstacle to the success of chemotherapy is poorly targeted treatment. There are two main reasons for this: the failure to use the best medicines clinically and the poor selectivity of most medicines today, leading to the destruction of normal tissues and functions. Including angiogenesis in-hibitor [